Bladder cancer
L Dyrskjøt, DE Hansel, JA Efstathiou… - Nature Reviews …, 2023 - nature.com
Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …
Neoadjuvant therapy for pancreatic cancer
Patients with localized pancreatic ductal adenocarcinoma (PDAC) are best treated with
surgical resection of the primary tumour and systemic chemotherapy, which provides …
surgical resection of the primary tumour and systemic chemotherapy, which provides …
[HTML][HTML] Perioperative durvalumab for resectable non–small-cell lung cancer
JV Heymach, D Harpole, T Mitsudomi… - … England Journal of …, 2023 - Mass Medical Soc
Background Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients
with resectable non–small-cell lung cancer (NSCLC). Perioperative regimens may combine …
with resectable non–small-cell lung cancer (NSCLC). Perioperative regimens may combine …
[PDF][PDF] 中国胃癌筛查与早诊早治指南(2022, 北京).
赫捷, 陈万青, 李兆申, 李霓, 任建松, 田金徽… - Chinese Journal of …, 2022 - dzrmyy.com
胃癌是中国常见的恶性肿瘤之一, 严重威胁居民生命健康. 胃癌高风险人群接受筛查和早诊,
早治能够有效降低胃癌的发病率和死亡率. 制定符合中国国情的胃癌筛查与早诊早治指南 …
早治能够有效降低胃癌的发病率和死亡率. 制定符合中国国情的胃癌筛查与早诊早治指南 …
Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology
JA Ajani, TA D'Amico, DJ Bentrem, J Chao… - Journal of the National …, 2022 - jnccn.org
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …
Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology
Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly
as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the …
as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the …
[HTML][HTML] Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma
Background In a pilot study involving patients with cutaneous squamous-cell carcinoma, a
high percentage of patients had a pathological complete response with the use of two doses …
high percentage of patients had a pathological complete response with the use of two doses …
Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology
RI Haddad, L Bischoff, D Ball, V Bernet… - Journal of the National …, 2022 - jnccn.org
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …
Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology
JA Ajani, TA D'Amico, DJ Bentrem, D Cooke… - Journal of the National …, 2023 - jnccn.org
Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …
health problem. Esophageal cancers are histologically classified as squamous cell …
NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines
JJ Caudell, ML Gillison, E Maghami, S Spencer… - Journal of the National …, 2022 - jnccn.org
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity
(including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer …
(including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer …